RECRUITING

An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The aim of this study is to evaluate the feasibility and acceptability of conducting a randomized trial of a brief psychoeducational intervention versus enhanced usual care for patients with locally advanced rectal cancer who are initiating neoadjuvant multimodality treatment.

Official Title

PATHWAYS: An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer

Quick Facts

Study Start:2023-09-21
Study Completion:2028-12
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05914766

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Age≥18 years
  2. 2. Within 8 weeks after documented decision to pursue multi-modality therapy for newly diagnosed LARC (i.e., stage II or III disease)
  3. 3. Able to complete study procedures English or with the assistance of an interpreter
  1. 1. Comorbid health condition that would interfere with study participation, as identified by cancer care team
  2. 2. Has undergone treatment for a prior colorectal cancer

Contacts and Locations

Study Contact

Kelsey Lau-Min, MD, MSCE
CONTACT
617-724-4000
klau-min@mgh.harvard.edu

Principal Investigator

Kelsey Lau-Min, MD, MSCE
PRINCIPAL_INVESTIGATOR
Massachusetts General Hospital

Study Locations (Sites)

Massachusetts General Hospital
Boston, Massachusetts, 02114
United States
Dana-Farber Cancer Institute
Boston, Massachusetts, 02215
United States

Collaborators and Investigators

Sponsor: Massachusetts General Hospital

  • Kelsey Lau-Min, MD, MSCE, PRINCIPAL_INVESTIGATOR, Massachusetts General Hospital

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-09-21
Study Completion Date2028-12

Study Record Updates

Study Start Date2023-09-21
Study Completion Date2028-12

Terms related to this study

Keywords Provided by Researchers

  • total neoadjuvant therapy
  • locally advanced rectal cancer
  • self efficacy
  • psychoeducational
  • multimodality treatment

Additional Relevant MeSH Terms

  • Rectal Cancer
  • Self Efficacy